These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 28489727

  • 1. Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study.
    Meijer B, Wilhelm AJ, Mulder CJJ, Bouma G, van Bodegraven AA, de Boer NKH.
    Ther Drug Monit; 2017 Aug; 39(4):399-405. PubMed ID: 28489727
    [Abstract] [Full Text] [Related]

  • 2. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
    Jharap B, de Boer NK, Stokkers P, Hommes DW, Oldenburg B, Dijkstra G, van der Woude CJ, de Jong DJ, Mulder CJ, van Elburg RM, van Bodegraven AA, Dutch Initiative on Crohn and Colitis.
    Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097
    [Abstract] [Full Text] [Related]

  • 3. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
    Armstrong L, Sharif JA, Galloway P, McGrogan P, Bishop J, Russell RK.
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1106-14. PubMed ID: 21929546
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
    Gilissen LP, Wong DR, Engels LG, Bierau J, Bakker JA, Paulussen AD, Romberg-Camps MJ, Stronkhorst A, Bus P, Bos LP, Hooymans PM, Stockbrügger RW, Neef C, Masclee AA.
    J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
    [Abstract] [Full Text] [Related]

  • 5. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM.
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [Abstract] [Full Text] [Related]

  • 6. A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel Disease.
    Mogensen DV, Brynskov J, Ainsworth MA, Nersting J, Schmiegelow K, Steenholdt C.
    J Crohns Colitis; 2018 Feb 28; 12(3):298-305. PubMed ID: 29145599
    [Abstract] [Full Text] [Related]

  • 7. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy.
    Bayoumy AB, Ansari AR, Mulder CJJ, Schmiegelow K, Florin T, De Boer NKH.
    Clin Pharmacokinet; 2024 Aug 28; 63(8):1089-1109. PubMed ID: 39031224
    [Abstract] [Full Text] [Related]

  • 8. The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.
    Gao X, Zhang FB, Ding L, Liu H, Wang XD, Chen BL, Bi HC, Xiao YL, Zhao LZ, Chen MH, Huang M, Hu PJ.
    Eur J Gastroenterol Hepatol; 2012 Aug 28; 24(8):958-64. PubMed ID: 22664938
    [Abstract] [Full Text] [Related]

  • 9. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?
    Heerasing NM, Ng JF, Dowling D.
    Intern Med J; 2016 Apr 28; 46(4):465-9. PubMed ID: 26425841
    [Abstract] [Full Text] [Related]

  • 10. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
    Dervieux T, Meyer G, Barham R, Matsutani M, Barry M, Boulieu R, Neri B, Seidman E.
    Clin Chem; 2005 Nov 28; 51(11):2074-84. PubMed ID: 16166171
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis.
    Wusk B, Kullak-Ublick GA, Rammert C, von Eckardstein A, Fried M, Rentsch KM.
    Eur J Gastroenterol Hepatol; 2004 Nov 28; 16(12):1407-13. PubMed ID: 15618853
    [Abstract] [Full Text] [Related]

  • 12. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
    Yarur AJ, Gondal B, Hirsch A, Christensen B, Cohen RD, Rubin DT.
    J Clin Gastroenterol; 2018 Jul 28; 52(6):537-544. PubMed ID: 28723860
    [Abstract] [Full Text] [Related]

  • 13. Hematologic indices as surrogate markers for monitoring thiopurine therapy in IBD.
    Kopylov U, Battat R, Benmassaoud A, Paradis-Surprenant L, Seidman EG.
    Dig Dis Sci; 2015 Feb 28; 60(2):478-84. PubMed ID: 25236422
    [Abstract] [Full Text] [Related]

  • 14. Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study.
    Jagt JZ, Pothof CD, Buiter HJC, van Limbergen JE, van Wijk MP, Benninga MA, de Boer NKH, de Meij TGJ.
    Dig Dis Sci; 2022 Jan 28; 67(1):241-251. PubMed ID: 33532972
    [Abstract] [Full Text] [Related]

  • 15. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
    Haines ML, Ajlouni Y, Irving PM, Sparrow MP, Rose R, Gearry RB, Gibson PR.
    Inflamm Bowel Dis; 2011 Jun 28; 17(6):1301-7. PubMed ID: 20812329
    [Abstract] [Full Text] [Related]

  • 16. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
    Gearry RB, Barclay ML, Roberts RL, Harraway J, Zhang M, Pike LS, George PM, Florkowski CM.
    Intern Med J; 2005 Oct 28; 35(10):580-5. PubMed ID: 16207256
    [Abstract] [Full Text] [Related]

  • 17. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
    Wall GC, Muktar H, Effken C, Mahajan PB.
    Pharmacotherapy; 2018 Feb 28; 38(2):259-270. PubMed ID: 29197117
    [Abstract] [Full Text] [Related]

  • 18. Determination of Concentrations of Azathioprine Metabolites 6-Thioguanine and 6-Methylmercaptopurine in Whole Blood With the Use of Liquid Chromatography Combined With Mass Spectrometry.
    Zochowska D, Zegarska J, Hryniewiecka E, Samborowska E, Jazwiec R, Tszyrsznic W, Borowiec A, Dadlez M, Paczek L.
    Transplant Proc; 2016 Jun 28; 48(5):1836-9. PubMed ID: 27496503
    [Abstract] [Full Text] [Related]

  • 19. Metabolite monitoring to guide thiopurine therapy in systemic autoimmune diseases.
    Chapdelaine A, Mansour AM, Troyanov Y, Williamson DR, Doré M.
    Clin Rheumatol; 2017 Jun 28; 36(6):1341-1348. PubMed ID: 28130685
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy.
    Derijks LJ, Gilissen LP, Engels LG, Bos LP, Bus PJ, Lohman JJ, Curvers WL, Van Deventer SJ, Hommes DW, Hooymans PM.
    Ther Drug Monit; 2004 Jun 28; 26(3):311-8. PubMed ID: 15167634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.